510(k) K152155
K152155 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "ARCHITECT 2nd Generation Testosterone". The FDA issued a decision of Substantially Equivalent on Dec 17, 2015. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. Abbott Laboratories has 889 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 17, 2015
- Date Received
- Aug 3, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, Testosterones And Dihydrotestosterone
- Device Class
- Class I
- Regulation Number
- 862.1680
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Abbott Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.